ALEXANDRA WACLAWSKI: Open Payments
NPI 1700307246 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,768 in 73 payments from 15 companies in 2025. Trend: 2023 $884 · 2024 $3,979 · 2025 $1,768
Food & beverage: $1,659Education: $109
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $461 |
| Lilly USA, LLC | 9 | $237 |
| ABBVIE INC. | 12 | $216 |
| Regeneron Healthcare Solutions, Inc. | 4 | $186 |
| UCB, Inc. | 12 | $165 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $145 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Amgen Inc. | 4 | $77 |
| Organon LLC | 3 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Bimzelx, TALTZ, EBGLYSS, OTEZLA, COSENTYX.
Industry payments across NY — which companies pay providers there.
